Rheopheresis for Dry Age-Related Macular Degeneration (AMD ...

Recommendations

Info

heopherese-zentrum.de o heo.com he International pheresis Competence ers pheresis-research.org - Registry Report Update March, March, 2005 4379 recorded Rheopheresis treatment 717 treated patients (all indications) mean age 66 years 476 pts. with AMD 66% mean age 74 years 241 pts. with other indications 34% mean age 55 years
Number of patients oNet Registry Update March 2005 Age Distribution of Patients All indications AMD 240 210 180 150 120 90 60 30 0 n = 714 0-20 21-30 31-40 41-50 51-60 61-70 71-80 81-90 91-100 Years SSHL, tinnitus Number of patients Number of patients 210 180 150 120 90 60 30 45 40 35 30 25 20 15 10 5 0 0 n = 474 0-20 21-30 31-40 41-50 51-60 61-70 71-80 81-90 91-100 Years n = 172 0-20 21-30 31-40 41-50 51-60 61-70 71-80 81-90 91-100 Years 21% of AMD patients were ≥ 80 years
Page 1 and 2: 26th Annual Meeting April 27 - 30,
Page 3 and 4: heopheresis Blood Plasmaseparation
Page 5 and 6: Rheopheresis for AMD Mechanism of A
Page 7 and 8: Rheopheresis for Microcirculatory D
Page 9 and 10: Rheopheresis for AMD www.rheo.com M
Page 11 and 12: Rheopheresis for AMD Regulatory Sta
Page 14 and 15: Adverse events/side effects: Advers
Page 18 and 19: oNet Registry Update March 2005 dve
Page 20 and 21: oNet Registry Update March 2005 dve
Page 22 and 23: oNet Registry Update March 2005 Hyp
Page 24 and 25: oNet Registry Update March 2005 Hyp
Page 26 and 27: hange in ETDRS-Lines ETDRS ETDRS-Li
Page 28: RheoNet - Registry Summary RheoNet-

Rheopheresis for Dry Age-Related Macular Degeneration (AMD ...

You also want an ePaper? Increase the reach of your titles

Delete template?

Save as template?